Home Page About Us Contribute




Escort, Inc.

Tweets by @CrittendenAuto










By accessing/using The Crittenden Automotive Library/CarsAndRacingStuff.com, you signify your agreement with the Terms of Use on our Legal Information page. Our Privacy Policy is also available there.

Qualification of Drivers; Exemption Applications; Diabetes Mellitus

American Government Special Collections Reference Desk

American Government

Qualification of Drivers; Exemption Applications; Diabetes Mellitus

Larry W. Minor
Federal Motor Carrier Safety Administration
19 September 2018


[Federal Register Volume 83, Number 182 (Wednesday, September 19, 2018)]
[Notices]
[Pages 47399-47407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20294]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA 2018-0205]


Qualification of Drivers; Exemption Applications; Diabetes 
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 57 individuals 
for an exemption from the prohibition in the Federal Motor Carrier 
Safety Regulations (FMCSRs) against persons with insulin-treated 
diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in 
interstate commerce. If granted, the exemptions would enable these 
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before October 19, 2018.

ADDRESSES: You may submit comments identified by the Federal Docket 
Management System (FDMS) Docket No. FMCSA-2018-0205 using any of the 
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting 
comments.
     Mail: Docket Management Facility; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, 
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140, 
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., 
ET, Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    To avoid duplication, please use only one of these four methods. 
See the ``Public Participation'' portion of the SUPPLEMENTARY 
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, 
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., ET, 
Monday through Friday, except Federal holidays. If you have questions 
regarding viewing or submitting material to the docket, contact Docket 
Services, telephone (202) 366-9826.

SUPPLEMENTARY INFORMATION: 

[[Page 47400]]

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this 
notice (Docket No. FMCSA-2018-0205), indicate the specific section of 
this document to which each comment applies, and provide a reason for 
each suggestion or recommendation. You may submit your comments and 
material online or by fax, mail, or hand delivery, but please use only 
one of these means. FMCSA recommends that you include your name and a 
mailing address, an email address, or a phone number in the body of 
your document so that FMCSA can contact you if there are questions 
regarding your submission.
    To submit your comment online, go to http://www.regulations.gov, 
put the docket number, FMCSA 2018-0205, in the keyword box, and click 
``Search.'' When the new screen appears, click on the ``Comment Now!'' 
button and type your comment into the text box on the following screen. 
Choose whether you are submitting your comment as an individual or on 
behalf of a third party and then submit.
    If you submit your comments by mail or hand delivery, submit them 
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for 
copying and electronic filing. If you submit comments by mail and would 
like to know that they reached the facility, please enclose a stamped, 
self-addressed postcard or envelope.
    FMCSA will consider all comments and material received during the 
comment period.

B. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice 
as being available in the docket, go to http://www.regulations.gov. 
Insert the docket number, FMCSA 2018-0205, in the keyword box, and 
click ``Search.'' Next, click the ``Open Docket Folder'' button and 
choose the document to review. If you do not have access to the 
internet, you may view the docket online by visiting the Docket 
Management Facility in Room W12-140 on the ground floor of the DOT West 
Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 
a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays.

C. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the 
public to better inform its rulemaking process. DOT posts these 
comments, without edit, including any personal information the 
commenter provides, to www.regulations.gov, as described in the system 
of records notice (DOT/ALL-14 FDMS), which can be reviewed at 
www.dot.gov/privacy.

II. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption 
from the FMCSRs for a five-year period if it finds ``such exemption 
would likely achieve a level of safety that is equivalent to or greater 
than the level that would be achieved absent such exemption.'' The 
statute also allows the Agency to renew exemptions at the end of the 
five-year period. FMCSA grants exemptions from the FMCSRs for a two-
year period to align with the maximum duration of a driver's medical 
certification.
    The 57 individuals listed in this notice have requested an 
exemption from the diabetes prohibition in 49 CFR 391.41(b)(3). 
Accordingly, the Agency will evaluate the qualifications of each 
applicant to determine whether granting the exemption will achieve the 
required level of safety mandated by statute.
    The physical qualification standard for drivers regarding diabetes 
found in 49 CFR 391.41(b)(3) states that a person is physically 
qualified to drive a CMV if that person has no established medical 
history or clinical diagnosis of diabetes mellitus currently requiring 
insulin for control. The Agency established the current requirement for 
diabetes in 1970 because several risk studies indicated that drivers 
with diabetes had a higher rate of crash involvement than the general 
population.
    FMCSA established its diabetes exemption program, based on the 
Agency's July 2000 study entitled ``A Report to Congress on the 
Feasibility of a Program to Qualify Individuals with Insulin-Treated 
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the 
Transportation Act for the 21st Century.'' The report concluded that a 
safe and practicable protocol to allow some drivers with ITDM to 
operate CMVs is feasible. FMCSA published two notices in the Federal 
Register outlining the current protocol for allowing such drivers to 
operate CMVs in interstate commerce (Sep. 3, 2003, 68 FR 52441 and Nov. 
8, 2005, 70 FR 67777). All of the requirements set out in the September 
3, 2003, notice, except as modified by the notice in the Federal 
Register on November 8, 2005, remain in effect.

III. Qualifications of Applicants

Joseph J. Arena, Jr

    Mr. Arena, 63, has had ITDM since 2015. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Arena understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Arena meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Daniel C. Avants

    Mr. Avants, 55, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Avants understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Avants meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Washington.

Danny Bailey

    Mr. Bailey, 60, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Bailey understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Bailey meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist

[[Page 47401]]

examined him in 2018 and certified that he does not have diabetic 
retinopathy. He holds a Class A CDL from Texas.

Ryan P. Bankert

    Mr. Bankert, 41, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Bankert understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Bankert meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Jordan D. Braun

    Mr. Braun, 26, has had ITDM since 2003. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Braun understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Braun meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Minnesota.

David W. Buckley

    Mr. Buckley, 57, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Buckley understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Buckley meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Connecticut.

Travis R. Capesius

    Mr. Capesius, 21, has had ITDM since 2005. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Capesius understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Capesius meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Iowa.

Delquan S. Carter

    Mr. Carter, 28, has had ITDM since 2011. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Carter understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Carter meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Alabama.

Christopher J. Epplin

    Mr. Epplin, 33, has had ITDM since 1999. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Epplin understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Epplin meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class B CDL from Illinois.

Eugenio Esparza, Jr

    Mr. Esparza, 52, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Esparza understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Esparza meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class B CDL from Texas.

Brian L. Fairchild

    Mr. Fairchild, 52, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Fairchild understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Fairchild meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Idaho.

Stephen A. Fleming

    Mr. Fleming, 49, has had ITDM since 1979. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Fleming understands 
diabetes management and monitoring, has stable control of his diabetes 
using

[[Page 47402]]

insulin, and is able to drive a CMV safely. Mr. Fleming meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Minnesota.

Luigi Forcellati

    Mr. Forcellati, 76, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Forcellati understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Forcellati meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he has stable 
nonproliferative diabetic retinopathy. He holds an operator's license 
from New Jersey.

Daniel J. Garcia

    Mr. Garcia, 21, has had ITDM since 2015. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Garcia understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Garcia meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from California.

Derek A. Garibay

    Mr. Garibay, 52, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Garibay understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Garibay meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Colorado.

Caleb K. George

    Mr. George, 53, has had ITDM since 1996. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. George understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. George meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Rhode Island.

Dylan M. Graham

    Mr. Graham, 25, has had ITDM since 1997. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Graham understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Graham meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Michigan.

Donald D. Gueiss

    Mr. Gueiss, 51, has had ITDM since 2009. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Gueiss understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Gueiss meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds an operator's license from North 
Carolina.

Michael W. Hammarsten

    Mr. Hammarsten, 65, has had ITDM since 2014. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Hammarsten understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Hammarsten meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he has stable 
nonproliferative diabetic retinopathy. He holds a Class A CDL from 
Minnesota.

Robert L. Howell

    Mr. Howell, 67, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Howell understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Howell meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a class A CDL from Illinois.

Mitchell M. Huston

    Mr. Huston, 58, has had ITDM since 2014. His endocrinologist 
examined him in 2018 and certified that he has had no

[[Page 47403]]

severe hypoglycemic reactions resulting in loss of consciousness, 
requiring the assistance of another person, or resulting in impaired 
cognitive function that occurred without warning in the past 12 months 
and no recurrent (two or more) severe hypoglycemic episodes in the last 
five years. His endocrinologist certifies that Mr. Huston understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Huston meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Colorado.

Daniel J. Hutt

    Mr. Hutt, 48, has had ITDM since 2002. His endocrinologist examined 
him in 2018 and certified that he has had no severe hypoglycemic 
reactions resulting in loss of consciousness, requiring the assistance 
of another person, or resulting in impaired cognitive function that 
occurred without warning in the past 12 months and no recurrent (two or 
more) severe hypoglycemic episodes in the last five years. His 
endocrinologist certifies that Mr. Hutt understands diabetes management 
and monitoring, has stable control of his diabetes using insulin, and 
is able to drive a CMV safely. Mr. Hutt meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined 
him in 2018 and certified that he has stable nonproliferative diabetic 
retinopathy. He holds a Class B CDL from New York.

Curtis C. Jacobs

    Mr. Jacobs, 56, has had ITDM since 2014. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Jacobs understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Jacobs meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from North 
Carolina.

Steven M. Johnson

    Mr. Johnson, 48, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Johnson understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Johnson meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Indiana.

Dwyanne E. Johnson

    Mr. Johnson, 36, has had ITDM since 2012. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Johnson understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Johnson meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Colorado.

Christopher L. Johnston

    Mr. Johnston, 50, has had ITDM since 2016. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Johnston understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Johnston meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class A CDL from Georgia.

Gregory E. Jondle

    Mr. Jondle, 30, has had ITDM since 2010. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Jondle understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Jondle meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Iowa.

Steven Kinkead

    Mr. Kinkead, 57, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Kinkead understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Kinkead meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Missouri.

Alexander P. Laatz

    Mr. Laatz, 24, has had ITDM since 1998. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Laatz understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Laatz meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that

[[Page 47404]]

he does not have diabetic retinopathy. He holds an operator's license 
from Virginia.

David L. Lennie

    Mr. Lennie, 71, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Lennie understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Lennie meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class A CDL from Michigan.

Philip J. Linn

    Mr. Linn, 65, has had ITDM since 2010. His endocrinologist examined 
him in 2018 and certified that he has had no severe hypoglycemic 
reactions resulting in loss of consciousness, requiring the assistance 
of another person, or resulting in impaired cognitive function that 
occurred without warning in the past 12 months and no recurrent (two or 
more) severe hypoglycemic episodes in the last five years. His 
endocrinologist certifies that Mr. Linn understands diabetes management 
and monitoring, has stable control of his diabetes using insulin, and 
is able to drive a CMV safely. Mr. Linn meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him 
in 2018 and certified that he does not have diabetic retinopathy. He 
holds a Class A CDL from Ohio.

Raul Martinez

    Mr. Martinez, 60, has had ITDM since 2014. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Martinez understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Martinez meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class A CDL from Texas.

Lance E. May

    Mr. May, 46, has had ITDM since 2018. His endocrinologist examined 
him in 2018 and certified that he has had no severe hypoglycemic 
reactions resulting in loss of consciousness, requiring the assistance 
of another person, or resulting in impaired cognitive function that 
occurred without warning in the past 12 months and no recurrent (two or 
more) severe hypoglycemic episodes in the last five years. His 
endocrinologist certifies that Mr. May understands diabetes management 
and monitoring, has stable control of his diabetes using insulin, and 
is able to drive a CMV safely. Mr. May meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him 
in 2018 and certified that he does not have diabetic retinopathy. He 
holds a Class B CDL from Pennsylvania.

Terry A. McCoy

    Mr. McCoy, 60, has had ITDM since 2016. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. McCoy understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. McCoy meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds an operator's license from Georgia.

Brian K. McGowan

    Mr. McGowan, 54, has had ITDM since 2013. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. McGowan understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. McGowan meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Arkansas.

Michael D. Mervenne

    Mr. Mervenne, 56, has had ITDM since 2008. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Mervenne understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Mervenne meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds an operator's license from 
Michigan.

Kendrick D. Miller

    Mr. Miller, 41, has had ITDM since 2013. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Miller understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Miller meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from North 
Carolina.

William D. Murphy

    Mr. Murphy, 48, has had ITDM since 2016. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist

[[Page 47405]]

certifies that Mr. Murphy understands diabetes management and 
monitoring, has stable control of his diabetes using insulin, and is 
able to drive a CMV safely. Mr. Murphy meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him 
in 2018 and certified that he does not have diabetic retinopathy. He 
holds an operator's license from West Virginia.

Babykutty Oommen

    Mr. Oommen, 59, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Oommen understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Oommen meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds an operator's license from 
Illinois.

Miguel A. Orozco

    Mr. Orozco, 61, has had ITDM since 2006. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Orozco understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Orozco meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class B CDL from New Jersey.

Arthur W. Pahmeier

    Mr. Pahmeier, 61, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Pahmeier understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Pahmeier meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2016 and certified that he has stable 
nonproliferative diabetic retinopathy. He holds a Class A CDL from 
Indiana.

Dale W. Paul

    Mr. Paul, 23, has had ITDM since 2006. His endocrinologist examined 
him in 2018 and certified that he has had no severe hypoglycemic 
reactions resulting in loss of consciousness, requiring the assistance 
of another person, or resulting in impaired cognitive function that 
occurred without warning in the past 12 months and no recurrent (two or 
more) severe hypoglycemic episodes in the last five years. His 
endocrinologist certifies that Mr. Paul understands diabetes management 
and monitoring, has stable control of his diabetes using insulin, and 
is able to drive a CMV safely. Mr. Paul meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined 
him in 2018 and certified that he does not have diabetic retinopathy. 
He holds an operator's license from California.

Jason J. Phillips

    Mr. Phillips, 35, has had ITDM since 2007. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Phillips understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Phillips meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from New Mexico.

Robert E. Piernik

    Mr. Piernik, 63, has had ITDM since 2014. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Piernik understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Piernik meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he does not 
have diabetic retinopathy. He holds a Class A CDL from Florida.

Luc R. Poirier

    Mr. Poirier, 53, has had ITDM since 1967. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Poirier understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Poirier meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he has stable 
proliferative diabetic retinopathy. He holds an operator's license from 
Michigan.

Rick M. Provo

    Mr. Provo, 64, has had ITDM since 2010. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Provo understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Provo meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Indiana.

[[Page 47406]]

David W. Pywell

    Mr. Pywell, 58, has had ITDM since 2015. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Pywell understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Pywell meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he has stable 
nonproliferative diabetic retinopathy. He holds an operator's license 
from Idaho.

Nicholas A. Quairoli

    Mr. Quairoli, 34, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Quairoli understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Quairoli meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Florida.

Robert A. Raymond

    Mr. Raymond, 64, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Raymond understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Raymond meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Iowa.

Robert A. Rock, Jr.

    Mr. Rock, 51, has had ITDM since 2017. His endocrinologist examined 
him in 2018 and certified that he has had no severe hypoglycemic 
reactions resulting in loss of consciousness, requiring the assistance 
of another person, or resulting in impaired cognitive function that 
occurred without warning in the past 12 months and no recurrent (two or 
more) severe hypoglycemic episodes in the last five years. His 
endocrinologist certifies that Mr. Rock understands diabetes management 
and monitoring, has stable control of his diabetes using insulin, and 
is able to drive a CMV safely. Mr. Rock meets the requirements of the 
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him 
in 2018 and certified that he does not have diabetic retinopathy. He 
holds a Class A CDL from Rhode Island.

Hector R. Rodriguez

    Mr. Rodriguez, 54, has had ITDM since 2017. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Rodriguez understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Rodriguez meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Washington.

Samuel J. Shriver

    Mr. Shriver, 67, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Shriver understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Shriver meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from West 
Virginia.

Bradley A. Sundby

    Mr. Sundby, 58, has had ITDM since 2013. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Sundby understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Sundby meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
ophthalmologist examined him in 2018 and certified that he has stable 
proliferative diabetic retinopathy. He holds an operator's license from 
South Dakota.

Clayton A. Szydel

    Mr. Szydel, 53, has had ITDM since 2018. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Szydel understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Szydel meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Jeremy R. Tatro

    Mr. Tatro, 36, has had ITDM since 2012. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Tatro understands

[[Page 47407]]

diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Tatro meets the 
requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds a Class A CDL from Ohio.

Imelda Y. Tolentino

    Ms. Tolentino, 42, has had ITDM since 2011. Her endocrinologist 
examined her in 2018 and certified that she has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. Her endocrinologist certifies that Ms. Tolentino understands 
diabetes management and monitoring, has stable control of her diabetes 
using insulin, and is able to drive a CMV safely. Ms. Tolentino meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). Her 
ophthalmologist examined her in 2018 and certified that she has stable 
nonproliferative diabetic retinopathy. She holds an operator's license 
from Arkansas.

Birt F. Wilkerson, Jr.

    Mr. Wilkerson, 67, has had ITDM since 2000. His endocrinologist 
examined him in 2018 and certified that he has had no severe 
hypoglycemic reactions resulting in loss of consciousness, requiring 
the assistance of another person, or resulting in impaired cognitive 
function that occurred without warning in the past 12 months and no 
recurrent (two or more) severe hypoglycemic episodes in the last five 
years. His endocrinologist certifies that Mr. Wilkerson understands 
diabetes management and monitoring, has stable control of his diabetes 
using insulin, and is able to drive a CMV safely. Mr. Wilkerson meets 
the requirements of the vision standard at 49 CFR 391.41(b)(10). His 
optometrist examined him in 2018 and certified that he does not have 
diabetic retinopathy. He holds an operator's license from Texas.

IV. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests 
public comment from all interested persons on the exemption petitions 
described in this notice. We will consider all comments received before 
the close of business on the closing date indicated in the dates 
section of the notice.

    Issued on: September 13, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-20294 Filed 9-18-18; 8:45 am]
BILLING CODE 4910-EX-P

Connect with The Crittenden Automotive Library

The Crittenden Automotive Library at Google+ The Crittenden Automotive Library on Facebook The Crittenden Automotive Library on Instagram The Crittenden Automotive Library at The Internet Archive The Crittenden Automotive Library on Pinterest The Crittenden Automotive Library on Twitter The Crittenden Automotive Library on Tumblr  
 
 


The Crittenden Automotive Library

Home Page    About Us    Contribute